Corticotropin gel for acute gout flares
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.
This study tests two doses of a medicine called Purified Cortrophin Gel for people having a gout flare that started in the last 5 days. It might be an option if other treatments haven't worked or aren't safe for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- Your current gout flare started within the last 5 days.
- You have had at least one gout flare in the past 12 months.
- Other standard gout treatments (like NSAIDs or colchicine) have not worked, caused side effects, or are not right for you.
- You are willing to use a cellphone to complete surveys.
- You are not pregnant, breastfeeding, or planning to become pregnant and are using effective contraception if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, ABP-745, for people having an acute gout flare. It aims to see if the drug is safe and helps reduce pain and inflammation.
This study tests a medicine called SSGJ-613 to see if it can reduce gout flares when people start treatment to lower uric acid. It may help people who have frequent gout attacks.
This study compares two different treatment goals for a blood level called urate in people with gout. The goal is to see which approach lowers gout flares better while helping people feel better.
This study tests whether starting a new gout medicine called dotinurad at different times after a flare begins can help the flare go away faster. It may help people who have frequent gout attacks or certain health conditions.
This trial tests a combination of two medicines, etoricoxib and betamethasone, for quickly treating a painful gout flare. It is for people who have had gout before and whose current attack started within two days.
This trial studies dapansutrile tablets (OLT1177) to see how well they work for people in the first 4 days of an acute gout flare. It may help reduce pain and inflammation in the specific joint where your gout is flaring.
Hear when a new Gout Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.